Aug 20 - Bayer’s sale of its animal health business to Elanco for up to $7.6 bln leaves the German firm free to scratch bigger itches. Its shares have plunged since it bought Monsanto for $63 bln last year amid a flurry of lawsuits. Ed Cropley explains what’s next in Bayer’s delousing.
from Reuters Video: Breakingviews https://ift.tt/2TSvv0r
via
IFTTT